Parexel International posts

Feed

Parexel has researched the way to revenue growth

The choppy market conditions sometime give the impression that growth plays do not exist, but that is far from the case, with Parexel International (NASDAQ: PRXL) providing the evidence.

Parexel International is a leading contract research organization and boasts some of the world's largest drug, biotech and medical device companies among its clients.

Analysts like PRXL's operational breadth: its clinical research services unit offers clinical trial and data management, study design and recruitment, biostatistical analysis, clinical pharmacology, industry training, and publishing services.

Continue reading Parexel has researched the way to revenue growth

Symbol Lookup
IndexesChangePrice
DJIA-74.9212,454.83
NASDAQ-1.852,837.53
S&P 500-2.861,317.82

Last updated: May 27, 2012: 12:00 PM

Hot Stocks

General Electric

19.20-0.05(-0.26)

Alcoa

8.630.00(0.00)

Apple Inc

562.29-3.03(-0.54)

Google Inc 'A'

591.53-12.13(-2.01)

Bank of America

7.15+0.01(+0.14)

Wal-Mart Stores

65.31+0.24(+0.37)

Exxon Mobil Corp

82.08-0.53(-0.64)

Ford

10.60+0.01(+0.09)

Citigroup

26.47-0.19(-0.71)

IBM

194.30-1.79(-0.91)

Yahoo

15.36+0.01(+0.07)

Starbucks

54.56-0.20(-0.37)

Microsoft

29.06-0.01(-0.03)

Home Depot

49.44-0.27(-0.54)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1338134440690 ms.